title: How to best preserve oocytes in female cancer patients exposed to DNA damage inducing therapeutics.
authors.forename: K
authors.initials: K
authors.lastname: Hutt
authors.forename: J B
authors.initials: JB
authors.lastname: Kerr
authors.forename: C L
authors.initials: CL
authors.lastname: Scott
authors.forename: J K
authors.initials: JK
authors.lastname: Findlay
authors.forename: A
authors.initials: A
authors.lastname: Strasser
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017209:Apoptosis / Q000502:physiology*; D002945:Cisplatin / Q000009:adverse effects*; D005260:Female; D009865:Oocytes / Q000502:physiology*; D010984:Platinum / Q000009:adverse effects*; D015398:Signal Transduction / Q000502:physiology*; D016159:Tumor Suppressor Protein p53 / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D016159:Tumor Suppressor Protein p53; D010984:Platinum; D002945:Cisplatin